pamidronate has been researched along with mannitol in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alferiev, IS; Amidon, GL; Breuer, E; Cohen, H; El Hanany-Rozen, N; Ezra, A; Gati, I; Golomb, G; Hoffman, A; Mönkkönen, J; Stepensky, D; Törmälehto, S; Weiss, G | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Alferiev, IS; Breuer, E; Cohen, H; Ezra, A; Golomb, G; Hägele, G; Hoffman, A; Mönkkönen, J; Ornoy, A; Patlas, N; Pinto, T; Sagi, H; Seibel, MJ; Solomon, V; Stepensky, D | 1 |
| Cai, W; Gao, YJ; Li, PW; Liu, B; Mao, GG; Wang, SJ; Zhang, G; Zhang, Y; Zhou, YF | 1 |
1 review(s) available for pamidronate and mannitol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for pamidronate and mannitol
| Article | Year |
|---|---|
[Phase II randomized clinical trail of zoledronic acid in treating metastatic bone pain of malignancy].
Topics: Adult; Aged; Bone Density Conservation Agents; Bone Neoplasms; Diphosphonates; Double-Blind Method; Female; Humans; Imidazoles; Male; Mannitol; Middle Aged; Pain, Intractable; Pamidronate; Prospective Studies; Zoledronic Acid | 2005 |
4 other study(ies) available for pamidronate and mannitol
| Article | Year |
|---|---|
A peptide prodrug approach for improving bisphosphonate oral absorption.
Topics: Administration, Oral; Alendronate; Animals; Biological Availability; Caco-2 Cells; Carrier Proteins; Chemical Precipitation; Dipeptides; Diphosphonates; Durapatite; Humans; Injections, Intravenous; Intestinal Absorption; Pamidronate; Peptide Transporter 1; Prodrugs; Rats; Symporters; Tissue Distribution | 2000 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
Synthesis and preclinical pharmacology of 2-(2-aminopyrimidinio) ethylidene-1,1-bisphosphonic acid betaine (ISA-13-1)-a novel bisphosphonate.
Topics: Administration, Oral; Alendronate; Animals; Antineoplastic Agents; Betaine; Bone Diseases; Bone Neoplasms; Calcium; Capsules; Carcinoma 256, Walker; Cell Line; Diphosphonates; Diuretics, Osmotic; Durapatite; Injections, Intravenous; Intestinal Absorption; Macrophages; Male; Mannitol; Osteogenesis; Pamidronate; Rats; Rats, Inbred Strains; Tight Junctions; Tissue Distribution | 1999 |